ARCHIVES

DCT Board Approves Drug Development Recompetition

This article is from The Cancer Letter archive.

Vol. 16 No. 46 | November 30, 1990

Download PDF Visit The Full Archive

Related Articles

Hopkins Begins Review Of All Studies After OHRP Lifts Research Suspension.

July 27, 2001

Seven New Initiatives For NIH Common Fund

February 26, 2010

NCI Grant Boosts UCLA Bladder Cancer Project

October 25, 2002

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

NCI Advisory Group, Other Cancer Meetings

July 29, 1983

After Congressional Inquiry, NCI Posts Ambiguous Statement On Abortion And Breast Cancer Risk

December 13, 2002